Amicus Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.03.21	Amicus Therapeutics-Aktie: Einschätzungen und Kursziele der Analysten im März (finanzen.net)
28.02.21	Amicus Therapeutics-Aktie: Experten empfehlen Amicus Therapeutics im Februar mehrheitlich zu halten (finanzen.net)
27.02.21	Ausblick: Amicus Therapeutics informiert über die jüngsten Quartalsergebnisse (finanzen.net)
03.12.20	BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK (RTTNews)
30.11.20	So schätzen die Analysten die Amicus Therapeutics-Aktie im November 2020 ein (finanzen.net)
28.10.20	AUPH Initiates VOCOVID Trial, KALA Gets FDA Nod, NVAX Expands COVID-19 Vaccine Study Size In UK (RTTNews)
27.10.20	ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz (RTTNews)
09.08.20	Ausblick: Amicus Therapeutics präsentiert Quartalsergebnisse (finanzen.net)
17.06.20	AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact (RTTNews)
07.05.20	Ausblick: Amicus Therapeutics stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net)
07.08.19	Ausblick: Amicus Therapeutics legt Quartalsergebnis vor (finanzen.net)
06.05.19	Ausblick: Amicus Therapeutics gewährt Anlegern Blick in die Bücher (finanzen.net)
26.02.19	Ausblick: Amicus Therapeutics öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)
03.11.18	Ausblick: Amicus Therapeutics vermeldet Zahlen zum jüngsten Quartal (finanzen.net)
26.07.18	Biotech Stocks Facing FDA Decision In August (RTTNews)
27.06.18	PTIE Bleeds On FDA Snub, Starpharma Shines, FOLD Unfolds Plans, AKAO Disappoints (RTTNews)
23.03.18	Fabry Disease Drug OK'd In Japan, FDA Delays Decision On Azedra, HTGM On Watch (RTTNews)
16.02.18	PCRX Slumps On FDA Panel Feedback, DOVA Hits Record High, AGIO Up 38% YTD (RTTNews)
11.01.18	NVAX Turns Heads, EPZM On The Rise, TTOO Already Up 25%, GBT Hits Record High (RTTNews)
14.09.17	FDA Panel Nod For GSK's Shingles Vaccine, FOLD Beyond Essence, FENC Is Red Hot (RTTNews)
13.09.17	Amicus: Phase 3 SD-101 Study Fails To Meet Primary Endpoints - Quick Facts (RTTNews)
16.08.17	ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges (RTTNews)
04.08.17	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Gold Resource Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
21.07.17	Company Spotlight: Amicus (RTTNews)
19.07.17	Gainers & Losers Of July 18: CAPR, NVAX, TTOO, IMUC, SBPH... (RTTNews)
17.07.17	Technical Reports on Biotech Equities -- Amicus Therapeutics, Pulmatrix, Amgen, and Bioverativ (PR Newswire)
13.07.17	Amicus Therapeutics Pulling Back After Offering Announcement (RTTNews)
13.07.17	NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track (RTTNews)
12.07.17	Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment (PR Newswire)
12.07.17	Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment (PR Newswire)
12.07.17	Gainers & Losers Of July 11: ARNA, FOLD, VSTM, TOCA, GTHX... (RTTNews)
11.07.17	Amicus Says FDA Okays NDA Submission For Fabry Disease Treatment; Stock Up (RTTNews)
12.06.17	Breakfast Technical Briefing on Biotech Stocks -- CEL-SCI, Amicus Therapeutics, Galena Biopharma, and Cleveland BioLabs (PR Newswire)
06.04.17	Marin Mountain Bikes Recalls Bicycles Due to Fall, Crash Hazards (PR Newswire)
06.04.17	Biotech Stocks on Investors' Radar -- Merrimack Pharma, Amicus Therapeutics, CEL-SCI, and Cempra (PR Newswire)
02.03.17	Gainers & Losers Of Mar.1: DVAX, SKLN, FOLD, IPXL, QASM... (RTTNews)
10.02.17	Biotech Stocks on Investors' Radar -- Amicus Therapeutics, Cempra, Ophthotech, and Sarepta Therapeutics (PR Newswire)
06.02.17	The Biotech Market Grows as Demand for New Therapeutics Increases (PR Newswire)
09.01.17	FinancialBuzz.com: Advances in Biotechnology Sector (PR Newswire)
09.12.16	FOLD Slowly Unfolding, EBS Continues Contract Spree, HZNP Plunges On Trial Data (RTTNews)
02.12.16	Research Reports Coverage on Biotech Stocks -- Celldex Therapeutics, Amicus Therapeutics, Navidea Biopharma, and Concordia (PR Newswire)
29.11.16	FOLD Shrinks, JAZZ On Right Track, NVLS Choked Up, AAAP On Watch, NVRO Sues BSX (RTTNews)
29.11.16	Amicus Says FDA Didn't Grant Accelerated Approval For Migalastat; Stock Plunges (RTTNews)
29.11.16	Amicus Says FDA Didn't Grant Accelerated Approval For Migalastat; Stock Plunges (RTTNews)
02.10.15	Amicus May Not Submit NDA For Migalastat Monotherapy In US By Year End (RTTNews)
16.09.15	KOOL Tweaks Workforce, VNDA To Face FDA, XNPT Crashed For A Reason, TRIV Zooms (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Amicus Therapeutics IncShs

Aktien Top/Flop

Meistgelesene Nachrichten